Article

A recent study in the New England Journal of Medicine revealed potential benefits of ZMapp, an experimental immune-based treatment for Ebola studied within the PREVAIL II trial.

New grants through President Obama’s BRAIN Initiative will allow University of Minnesota researchers to dive deeper into the brain, developing new imaging technology with the potential to map and study neural activity to much greater detail.

University of Minnesota Medical School researchers identified a potential target for treating Alzheimer’s disease, which reversed memory loss in mice. The study could translate into new treatments and provides insight into what may be causing the disease.
 

Researchers have discovered that a protein found naturally in cells that provide some protection from viruses is responsible for creating mutations that drive resistance to tamoxifen treatment in breast cancer. Because the protein, known as APOBEC3B, is found in elevated quantities in other kinds of cancer cells, the finding explains differential responses to treatment and opens the door to boosting the effectiveness of tamoxifen and related breast cancer therapies that inhibit the ability of estrogen to stimulate tumor growth. 

New grants through President Obama’s BRAIN Initiative will allow University of Minnesota researchers to dive deeper into the brain, developing new imaging technology with the potential to map and study neural activity to much greater detail.

Dr. Tolar treats patients with a rare genetic skin blistering disorder called epidermolysis bullosa. Even if it never touches you or your family, the medical advances made through treating this disease probably will. In this Ted Talk, Dr.

New research from the University of Minnesota reveals endoglin as a critical factor in determining the fate of early undifferentiated cells during development. Endoglin, a receptor involved in cell signaling, has previously been known mostly for its function in blood vessels and angiogenesis.

In 1946, the University of Minnesota Medical School began forming an academic affiliation with the Minneapolis VA hospital, becoming one of the first schools in the country to enter into this landmark partnership and, to the best of our knowledge, the first to implement it.

It’s a $5.7 million question. At least that’s how much Demetri Yannopoulos, MD, just received from the National Institutes of Health to research how best to treat patients who have been resuscitated after sudden cardiac arrest.

In today’s medical technology world, there are no effective therapies for spinal cord injuries (SCIs).

Pages

Contact Communications

Kristine Elias
Director of Communications
Phone: 612-626-5066
Email: elias313@umn.edu

Please submit story ideas through our submission form.

Alyssa Dindorf | Duluth campus
Communications Specialist
218-726-8977
adindorf@d.umn.edu